SCHEMBL13601874

SCHEMBL13601874

CCCc1ccc(C(=O)Nc2ccccc2)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.55
RAB9A P51151 6/20 0.55
PPARG P37231 1/20 0.55
NCOA2 Q15596 1/20 0.55
NCOA1 Q15788 1/20 0.55
NCOA3 Q9Y6Q9 1/20 0.55
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
TP53 P04637 4/20 0.52
PTPN1 P18031 1/20 0.50
PTPN11 Q06124 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10162053 0.88 TP53 (0.58) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL10130729 0.81 NPC1 (0.54) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL1891734 0.79 MAPT (0.54) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL262537 0.77 DAO (0.50) TP53RXFP1LMNA
SCHEMBL10160826 0.76 NPC1 (0.66) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL27549875 0.75 NPC1 (0.67) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL15616360 0.73 ALDH1A1 (0.56) NPC1RAB9ATP53MAPTKMT2A
SCHEMBL3199622 0.73 ALDH1A1 (0.60) NPC1RAB9ATP53MAPTKMT2A
SCHEMBL13191768 0.73 ESRRG (0.55) NPC1RAB9APPARGNCOA2NCOA1
SCHEMBL12529829 0.73 RAB9A (0.60) NPC1RAB9ATP53MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324577-A1 6-11 Bicyclic Ketolide Derivatives OR YAT SUN 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324577-A1 6-11 Bicyclic Ketolide Derivatives AKR1C2, AKR1C3, AKR1C1 NPC1 387/4885RAB9A 2564/4885PPARG 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.